Mitogenesis Regenerative Medicine
- Vitamin IV Therapy
- PRP Therapy
- Ozone Therapy
- IV Therapy
- Hyperbaric Oxygen Therapy (HBOT)
Read the Chelation Therapy guide for the educational context behind this treatment category.
Scottsdale, AZ
If you are searching for iron overload treatment in Scottsdale, Arizona, confirm the diagnosis before booking chelation therapy: ask whether the office manages confirmed iron overload, not general detox concerns. Hereditary hemochromatosis is usually treated with therapeutic phlebotomy, meaning blood removal, rather than chelation. Chelation may suit some people with transfusion-related iron overload who cannot undergo phlebotomy. A hematologist can review ferritin and transferrin saturation to establish which approach fits your diagnosis; an advertised detox infusion does not establish that an office provides this care.
Scottsdale chelation offerings include offices along East Shea Boulevard and farther north near Northsight Boulevard and Raintree Drive. Compare those addresses with your route along Shea or Loop 101, especially if consultations, laboratory work and treatment require separate trips. Confirm the treatment location rather than relying on a Scottsdale mailing address, and ask whether follow-up testing can happen closer to home. Some offices sit near the Old Town core; compare travel along Scottsdale Road and Hayden Road when considering locations farther north.
Local advertisements include infusions in integrative and naturopathic medical offices, but iron overload treatment may involve a prescription taken by mouth instead. A first assessment should review your diagnosis, iron studies, transfusion history and medications before recommending a drug. For an infusion, ask who prescribes it, who administers it and who is available to respond to a reaction. Follow-up should track iron levels and drug-specific safety tests, with results shared with your usual clinician.
Request the medication's exact name, its pharmacy or supplier, and the reason it matches your condition. Ask for written risks and side effects, including potential kidney injury, the monitoring plan, and what would prompt stopping treatment. Confirm who reassesses the diagnosis and treatment if iron levels do not improve. A written quote should distinguish consultations, medication, administration, laboratory work and follow-up. Wellness chelation is commonly cash pay, and many advertised wellness uses lack FDA approval and convincing evidence of benefit.
Regenerated.com does not sell its organic listing order. Featured slots are capped and clearly labeled, while Verified means credential checks rather than payment. Regenerated.com is free for patients, and appearing in the directory is not an endorsement of a provider or treatment.
The national chelation therapy hub explains how the drugs work and where the evidence supports their use. For help interpreting this local list, read How to read a Regenerated city hub and Featured vs Verified vs organic.
Regulatory context
The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.
The Arizona Medical Board and Naturopathic Physicians Medical Board have investigated practitioners for chelation marketing tied to autism, cardiovascular disease, and chronic fatigue. Arizona has a sizable integrative medicine sector and a higher concentration of NDs administering IV chelation than most states. Enforcement actions have focused on misleading advertising and lack of informed consent rather than blanket prohibitions. The 2005 Pittsburgh pediatric death from a Na2EDTA infusion (wrong agent administered) shifted national board attention toward administration safety protocols.
Explore nearby
Available here
Explore statewide
Chelation Therapy in ArizonaNationwide
Chelation Therapy clinics across the US